Estimation of absorbed dose to the kidneys in patients after treatment with 177Lu-octreotate: comparison between methods based on planar scintigraphy
about
Renal function affects absorbed dose to the kidneys and haematological toxicity during ¹⁷⁷Lu-DOTATATE treatmentEvaluation of retinol binding protein 4 and carbamoylated haemoglobin as potential renal toxicity biomarkers in adult mice treated with (177)Lu-octreotateMethod dependence, observer variability and kidney volumes in radiation dosimetry of (177)Lu-DOTATATE therapy in patients with neuroendocrine tumours.IMPROVED PLANAR KIDNEY ACTIVITY CONCENTRATION ESTIMATE BY THE POSTERIOR VIEW METHOD IN 177LU-DOTATATE TREATMENTS.Radiation exposure of the spleen during (177)Lu-DOTATATE treatment and its correlation with haematological toxicity and spleen volumeA novel planar image-based method for bone marrow dosimetry in (177)Lu-DOTATATE treatment correlates with haematological toxicityPriming increases the anti-tumor effect and therapeutic window of 177Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1The Influence of Early Measurements Onto the Estimated Kidney Dose in [(177)Lu][DOTA(0),Tyr(3)]Octreotate Peptide Receptor Radiotherapy of Neuroendocrine Tumors.Kidney dosimetry in ¹⁷⁷Lu and ⁹⁰Y peptide receptor radionuclide therapy: influence of image timing, time-activity integration method, and risk factors.Software-assisted dosimetry in peptide receptor radionuclide therapy with 177Lutetium-DOTATATE for various imaging scenarios.Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity.Effect of calculation method on kidney dosimetry in 177Lu-octreotate treatment.
P2860
Q35244181-D01F9897-66CE-414D-8A18-E2AA225EBE79Q35675510-9E8A5B0A-7031-475A-ADDF-CB1003E79FF6Q36942728-E0A371CF-F965-4C11-946D-EA7AFF5F6B9FQ37016021-9E016CAA-3261-4849-ABB8-45D38C79CD06Q37156083-35A0E669-1352-4FBE-B0D4-399CC0D991B8Q37273187-8DD2FBD2-7880-419E-8547-0F22CA250AFEQ37590508-49E8CA17-0C25-450D-9E5A-3D9CC1AB602BQ41192086-F2C1AEB2-8A4B-4663-8C4D-2773CFF571A1Q43100704-9B088BE1-B1D5-4E0F-A63F-8CD1B95864E3Q47163935-AA5DA65B-1AC7-44B7-B40A-3FBAB50A922BQ52677878-83AD23A2-7531-47DE-821A-942078AE4218Q52982765-5434524C-3B35-4E93-BDCC-5CCD762B2D89
P2860
Estimation of absorbed dose to the kidneys in patients after treatment with 177Lu-octreotate: comparison between methods based on planar scintigraphy
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Estimation of absorbed dose to ...... s based on planar scintigraphy
@ast
Estimation of absorbed dose to ...... s based on planar scintigraphy
@en
type
label
Estimation of absorbed dose to ...... s based on planar scintigraphy
@ast
Estimation of absorbed dose to ...... s based on planar scintigraphy
@en
prefLabel
Estimation of absorbed dose to ...... s based on planar scintigraphy
@ast
Estimation of absorbed dose to ...... s based on planar scintigraphy
@en
P2093
P2860
P356
P1433
P1476
Estimation of absorbed dose to ...... s based on planar scintigraphy
@en
P2093
Bo Wängberg
Håkan Ahlman
Johanna B Svensson
Maria Larsson
Peter Bernhardt
P2860
P2888
P356
10.1186/2191-219X-2-49
P577
2012-09-24T00:00:00Z
P6179
1047761168